SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-19-065358
Filing Date
2019-11-19
Accepted
2019-11-19 13:26:55
Documents
2
Period of Report
2019-11-01

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 1567
2 EX-24.1 ex-24d1.htm EX-24.1 9011
  Complete submission text file 0001104659-19-065358.txt   11963
Mailing Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016
Business Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 0114318906360
HOOKIPA Pharma Inc. (Issuer) CIK: 0001760542 (see all company filings)

IRS No.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O HOOKIPA PHARMA INC. 350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240 NEW YORK NY 10118
Business Address
Necina Roman (Reporting) CIK: 0001794381 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38869 | Film No.: 191230389